Educational evidence summaries. No dosing, sourcing, or treatment instructions.
The Sports Integrity Desk explains current WADA rules and the implications of peptide-hormone prohibitions for tested athletes.
34 published notesAn evidence-led CJC-1295 and Ipamorelin Combination review focused on research gaps map, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity DeskAn evidence-led CJC-1295 and Ipamorelin Combination review focused on body composition claims, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity DeskAn evidence-led CJC-1295 and Ipamorelin Combination review focused on compounding evidence, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity DeskAn evidence-led CJC-1295 and Ipamorelin Combination review focused on fda status explained, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity DeskAn evidence-led CJC-1295 and Ipamorelin Combination review focused on endpoint hierarchy, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity DeskA claim-by-claim review separating measured GH and IGF-1 changes from unproven claims about fat loss, muscle growth, sleep, recovery and anti-aging.
Reviewed by Sports Integrity DeskAn evidence-led GHRH Analogues review focused on glucose and metabolic context, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity DeskAn evidence-led GHRH Analogues review focused on wada and sport rules, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity DeskA map of GHRH analogues and ghrelin-receptor secretagogues showing where CJC-1295, sermorelin, ipamorelin and GHRP-6 fit.
Reviewed by Sports Integrity Desk